Trials / Unknown
UnknownNCT03334019
Prevalence and Risk Factors for Coxiella Burnetii Seropositivity (Q Fever) Among Adults in Western France
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 559 (estimated)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Diseases naturally transmitted between animals and humans (zoonoses) are one of the leading causes of emergence or re-emergence of human infectious diseases. Non-foodborne zoonoses are commonly transmitted to human directly by contact with infected animals or contaminated environment. People working with animals such as farmers and veterinarians are particularly at risk of infection. Some zoonoses can also be transmitted indirectly thought the air and therefore can affect the general population. Example is Q fever, a disease caused by Coxiella burnetii, a bacterium highly resistant in the environment. In Western France, Q fever is endemic in cattle herds. To improve human zoonotic disease surveillance, the investigators will conduct a population based study in this area. The aims of the study are: 1. To assess seroprevalence of Coxiella burnetii infection among general population, farmers and veterinarians in Western France 2. To identify risk factors for Coxiella burnetii seropositivity in these populations
Detailed description
In order to estimate seroprevalence and risk factors for Coxiella burnetii infection in humans, the investigators will conduct a cross-sectional study in three groups: * blood donors at blood donation organizations (general population) * beef and dairy cattle farmers * veterinarians involved in a rural practice All the participants in the study will provide a blood sample and will fill in a questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood test | Data collected on general population, farmers and veterinarians though questionnaires and blood samples. |
Timeline
- Start date
- 2017-11-06
- Primary completion
- 2018-05-05
- Completion
- 2019-11-01
- First posted
- 2017-11-07
- Last updated
- 2018-05-30
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03334019. Inclusion in this directory is not an endorsement.